Bowel blood flow study for systemic sclerosis patients
Part of Digestive system, Heart & circulation, Immune system & allergy clinical trials.
This study looks at how systemic sclerosis (a disease that causes hardening of the skin and sometimes internal organs) affects the blood vessels in the gut. Researchers use ultrasound to see if there are changes in bowel blood flow, and how these may link to other health issues. This could help understand gut symptoms in scleroderma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of systemic sclerosis (scleroderma).
- You must be willing to have an ultrasound of your belly.
- You must not be pregnant or breastfeeding.
- You must not have other autoimmune diseases like lupus or rheumatoid arthritis.
- You must not have diabetes or serious health conditions like kidney failure or heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at changes in gut bacteria over time in people with systemic sclerosis (a connective tissue disease). It also compares them with healthy adults to understand what gut bacteria patterns may be linked to this condition.
This study looks at tiny particles in your blood to see if they can predict whether you might develop a serious lung condition called pulmonary arterial hypertension (high blood pressure in the lungs). It aims to find better ways to detect and manage this complication early.
This study tests whether a special diet can help reduce bloating and stomach discomfort in people with scleroderma (systemic sclerosis). You'll follow a specific meal plan to see if it improves your digestive symptoms.
This study follows adults with systemic sclerosis who are being seen at a specific hospital and asks for consent to store blood and other samples for future research. It may help researchers better understand the disease and develop better tests or treatments over time.
This study uses a special camera (SFDI) to take painless images of your skin to see how scleroderma affects it. You may also be asked for a small skin sample (biopsy) to help understand the condition better.
This trial uses PET/CT scans with special tracers to look at inflammation and activity in systemic sclerosis (scleroderma) soon after symptoms begin. It may help researchers understand what’s driving active disease and where it shows up in the body.
Hear when a new Systemic Sclerosis Associated GIT Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.